JP2016521567A5 - - Google Patents

Download PDF

Info

Publication number
JP2016521567A5
JP2016521567A5 JP2016518868A JP2016518868A JP2016521567A5 JP 2016521567 A5 JP2016521567 A5 JP 2016521567A5 JP 2016518868 A JP2016518868 A JP 2016518868A JP 2016518868 A JP2016518868 A JP 2016518868A JP 2016521567 A5 JP2016521567 A5 JP 2016521567A5
Authority
JP
Japan
Prior art keywords
sev
genome replication
vector
replication deficient
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016518868A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016521567A (ja
Filing date
Publication date
Priority claimed from EP13002972.1A external-priority patent/EP2813574B1/en
Application filed filed Critical
Publication of JP2016521567A publication Critical patent/JP2016521567A/ja
Publication of JP2016521567A5 publication Critical patent/JP2016521567A5/ja
Pending legal-status Critical Current

Links

JP2016518868A 2013-06-10 2014-06-10 半生呼吸器合胞体ウイルスワクチン Pending JP2016521567A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13002972.1A EP2813574B1 (en) 2013-06-10 2013-06-10 Semi-live respiratory syncytial virus vaccine
EP13002972.1 2013-06-10
PCT/EP2014/001576 WO2014198408A1 (en) 2013-06-10 2014-06-10 Semi-live respiratory syncytial virus vaccine

Publications (2)

Publication Number Publication Date
JP2016521567A JP2016521567A (ja) 2016-07-25
JP2016521567A5 true JP2016521567A5 (enExample) 2017-07-27

Family

ID=48578770

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016518868A Pending JP2016521567A (ja) 2013-06-10 2014-06-10 半生呼吸器合胞体ウイルスワクチン

Country Status (12)

Country Link
US (1) US20160346378A1 (enExample)
EP (2) EP2813574B1 (enExample)
JP (1) JP2016521567A (enExample)
KR (1) KR20160023769A (enExample)
CN (1) CN105473724A (enExample)
AU (1) AU2014280624A1 (enExample)
BR (1) BR112015030742A2 (enExample)
CA (1) CA2914826A1 (enExample)
EA (1) EA201592299A1 (enExample)
HK (1) HK1223643A1 (enExample)
MX (1) MX367094B (enExample)
WO (1) WO2014198408A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3309251A4 (en) * 2015-06-12 2019-03-13 Mie University HUMAN PARAIN FLUENZA TYPE 2 VIRUS VIRUS VECTOR AND VACCINE
CN106362144B (zh) * 2016-10-31 2021-02-09 武汉三利生物技术有限公司 呼吸道合胞病毒疫苗
EP3542818A4 (en) * 2016-11-17 2020-07-29 Japan as Represented by The Director-General of National Institute of Infectious Diseases VACCINE AGAINST INFECTIOUS DISEASES USING NON-INFECTIOUS PARAMYXOVIRUS PARTICLES

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6146642A (en) * 1998-09-14 2000-11-14 Mount Sinai School Of Medicine, Of The City University Of New York Recombinant new castle disease virus RNA expression systems and vaccines
AU2001264824A1 (en) * 2000-06-01 2001-12-11 St. Jude Children's Research Hospital Vaccine and gene therapy vector and methods of use thereof
DE102005006388A1 (de) * 2005-02-11 2006-08-24 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Replikationsdefiziente RNA-Viren als Impfstoffe
KR20080016955A (ko) * 2005-06-14 2008-02-22 디나벡크 가부시키가이샤 항체의 제작방법

Similar Documents

Publication Publication Date Title
JP2016521566A5 (enExample)
JP2017522907A5 (enExample)
JP2016539946A5 (enExample)
JP2013501038A5 (enExample)
JP2014530010A5 (enExample)
JP2014516536A5 (enExample)
JP2012530761A5 (enExample)
JP2014526883A5 (enExample)
JP2017511136A (ja) 腫瘍崩壊ワクシニアウィルス
JP2014503206A5 (enExample)
JP2016513115A5 (enExample)
JP2015164424A5 (enExample)
JP2017507181A5 (enExample)
JP2014519817A5 (enExample)
JP2012515557A5 (enExample)
JP2017502662A5 (enExample)
JP2018524019A5 (enExample)
JP2016513471A5 (enExample)
JP2016521567A5 (enExample)
JP2014502143A5 (enExample)
US20180161421A1 (en) Recombinant vaccinia virus having hemagglutinin protein genes derived from novel influenza viruses
US20160120974A1 (en) Semi-live respiratory syncytial virus vaccine
CN103316357B (zh) 携带rsv基因的重组流感病毒嵌合疫苗及其制备方法
Yonemitsu et al. Immunostimulatory virotherapy using recombinant Sendai virus as a new cancer therapeutic regimen
CN104001168A (zh) 主动免疫治疗慢性哮喘的呈递il-33的vlp疫苗构建方法